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CORRESPONDENCE
Caudal clonidine and apnea risk
SIR—I read with interest the challenging editorial by
Dr. L€onnqvist on the use of adjuncts with regional anes-
thesia (1). As with his previous work on the subject, I
commend his forward thinking and crisp review,
although I disagree with one specific recommendation.
In Table 1, he recommends the use of clonidine as an
adjunct to local anesthesia in a caudal epidural block in
ex-premature babies, neonates, and infants, and cites
five articles to support this practice. ‘Only one relevant
case report exists linking the use of adjunct clonidine to
postoperative apnea following awake caudal blockade
in an ex-premature baby’, he wrote (1).
For ex-premature infants and neonates, perioperative
respiratory events including apnea present the greatest
perioperative risk. Of the five citations listed to support
clonidine use in this population, four did not concern
the use of clonidine in humans. The fifth, a meta-
analysis by Engelman, includes no patients under age
6 months; and many of the studies with infants under
1 year failed to capture perioperative respiratory events
(2).
The case report he notes may be the only case he finds
relevant; however, it is common practice to use caudal
analgesia in conjunction with general anesthesia. A dec-
ade ago, Dr. Hansen found three cases concerning for
caudal clonidine-induced apnea (3). The case noted by
Dr. L€onnqvist detailed the use of two procedures, both
using caudal blocks, in the same patient; one contained
clonidine and one did not. This patient developed multi-
ple apneas following caudal clonidine, causing a pro-
longed hospital stay, and had no apneas with the
clonidine-free caudal block.
Caudal clonidine is increasingly being viewed as safe
for outpatient use for older children (4). A casual reader
may choose to give caudal clonidine to a patient at high
risk for apnea based on a cursory reading of Dr. L€onnq-
vist’s editorial. In view of the cases noted by
Dr. Hansen, the safety profile for patients at high risk of
apnea, such as ex-premature babies and neonates,
should be demonstrated before it is routinely recom-
mended.
In fact, Dr. L€onnqvist has previously supported this
general view. In an editorial he authored in 2005, he
admonished readers not to use untested drugs in chil-
dren’s neuraxial space (5). While there are multiple stud-
ies on the use of intrathecal clonidine in this population,
I submit that his recommendation of the use of caudal
clonidine in neonates and ex-premature infants is pre-
mature and should be withdrawn. My concern also
stems from personal experience, as I attended a brady-
cardic cardiac arrest in an ex-premature infant on the
inpatient ward. This arrest was caused by and preceded
by numerous apneas. This patient had received
1 lgkg1 caudal clonidine and general anesthesia hours
earlier, and no other causal factor could readily be
found.
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